Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Value-focused Drug Development Strategies of the Future

Mounting healthcare and R&D costs, high drug attrition rates leading to decreased numbers of new molecular entity approvals, and growing demands from regulators and payers indicate that a paradigm shift is needed to improve efficiency and productivity across the drug development continuum.

Author(s): Craig Rayner
Solution: Clinical Pharmacology Strategy, Drug Development & Regulatory Strategy
Publication: Australasian BioTechnology
More Info
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog